Action CDXC CHROMADEX CORP
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Communiqués Chromadex Corp OTC Bulletin Board

Actions

CDXC

US1710771007

Cours en clôture OTC Bulletin Board
Autres places de cotation
- USD - Graphique intraday de Chromadex Corp
07/06 Mise à jour sectorielle : Les actions du secteur de la santé en hausse en fin d'après-midi MT
07/06 ChromaDex annonce que la FDA américaine a accordé au NRC la désignation de médicament orphelin et de maladie pédiatrique rare -- Les actions grimpent avant la cloche MT

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
ChromaDex Receives Exclusive U.S. FDA Orphan Drug Designation (ODD) and Rare Pediatric (RPD) Disease Designation for Nicotinamide Riboside Chloride (NRC) for the Treatment of Ataxia Telangiectasia (AT)
BU
ChromaDex to Participate in Renmark's Virtual Non-Deal Roadshow on Tuesday, June 11, 2024
AQ
ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, June 11, 2024
BU
ChromaDex's Niagen Wins Prestigious NutraIngredients EU Healthy Ageing Ingredient of the Year Award
AQ
ChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
BU
ChromaDex’s Niagen® Wins Prestigious NutraIngredients EU Healthy Ageing Ingredient of the Year Award
BU
ChromaDex Corporation Reports First Quarter 2024 Financial Results
BU
ChromaDex's NIAGEN, the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar Cellular Nutrition Cellular Energy Supplement
AQ
ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement
BU
ChromaDex Announces Nationwide Launch of Tru Niagen at The Vitamin Shoppe
AQ
ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®
BU
ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen at Sprouts Farmers Market
AQ
ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
BU
ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers Market
BU
ChromaDex Announces Tru Niagen is Now Third-Party Verified through the Alkemist Assured Transparency Program
AQ
ChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency Program
BU
ChromaDex : March 2024 Investor Presentation
PU
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results
BU
ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024
BU
ChromaDex to Participate in Renmark's Virtual Non-Deal Roadshow on Monday, February 12, 2024
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action CDXC
  4. Action CDXC
  5. Actualités Chromadex Corp
  6. Communiqués